Petenkova, Anastasiia http://orcid.org/0000-0002-7253-623X
Auger, Shelby A. http://orcid.org/0000-0003-2873-2580
Lamb, Jeffrey
Quellier, Daisy
Carter, Cody
To, On Tak
Milosevic, Jelena
Barghout, Rana
Kugadas, Abirami
Lu, Xiaoxiao
Geddes-McAlister, Jennifer http://orcid.org/0000-0002-4257-2096
Fichorova, Raina
Sykes, David B. http://orcid.org/0000-0002-9788-0221
Distefano, Mark D. http://orcid.org/0000-0002-2872-0259
Gadjeva, Mihaela http://orcid.org/0000-0002-9014-386X
Funding for this research was provided by:
Foundation for the National Institutes of Health (EY022054)
Article History
Received: 24 July 2022
Accepted: 29 April 2023
First Online: 13 May 2023
Competing interests
: DBS is a co-founder and holds equity in Clear Creek Bio and is a consultant and holds equity in SAFI Biosolutions. The remaining authors declare no competing interests.
: All animal experiments were performed following National Institutes of Health guidelines for housing and care of laboratory animals and performed in accordance with institutional regulations after protocol review and approval by BWH IACUC committee and were consistent with the Association for Research in Vision and Ophthalmology guidelines for studies in animals (Protocol number 2018N00002).